Prostate stromal cells express the progesterone receptor to control cancer cell mobility

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Yu, Yue ^a   Lee, Jennifer Suehyun ^a   Xie, Ning ^a   Li, Estelle ^a   Hurtado Coll, Antonio ^a   Fazli, Ladan ^a   Cox, Michael ^a   Plymate, Stephen ^b   Gleave, Martin ^a   Dong, Xuesen ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PROGESTERONE RECEPTOR; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MIDDLE AGED; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; CELL MOTION; GENE EXPRESSION REGULATION; MALE; METABOLISM; PATHOLOGY; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR INVASION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, PROGESTERONE; STROMAL CELLS;

EID: 84899752550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092714     Document Type: Article

References (49)

1. Erez N, Truitt M, Olson P, Arron ST, Hanahan D (2010) Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell 17: 135-147.
2. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, et al. (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 61: 8135-8142. (Pubitemid 33091604)
3. Wang Y, Sudilovsky D, Zhang B, Haughney PC, Rosen MA, et al. (2001) A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res 61: 6064-6072. (Pubitemid 32762541)
4. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, et al. (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8: 2912-2923. (Pubitemid 35025739)
5. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL (1993) Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13: 4513-4522. (Pubitemid 23220358)
6. Wang J, Sun Y, Song W, Nor JE, Wang CY, et al. (2005) Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal 17: 1578-1592. (Pubitemid 41253997)
7. Karlou M, Tzelepi V, Efstathiou E (2010) Therapeutic targeting of the prostate cancer microenvironment. Nat Rev Urol 7: 494-509.
8. Ao M, Franco OE, Park D, Raman D, Williams K, et al. (2007) Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 67: 4244-4253. (Pubitemid 46815071)
9. Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, et al. (2006) CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 66: 32-48. (Pubitemid 43005947)
10. Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC (2005) Upregulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res 65: 9891-9898. (Pubitemid 41541469)
11. Singh S, Singh UP, Grizzle WE, Lillard JW, Jr. (2004) CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 84: 1666-1676. (Pubitemid 39600573)
12. Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, et al. (2005) CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65: 465-472.
13. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, et al. (2004) Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 18: 1240-1242. (Pubitemid 39561563)
14. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, et al. (2002) Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62: 1832-1837. (Pubitemid 34408510)
15. Domanska UM, Timmer-Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, et al. (2012) CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Neoplasia 14: 709-718.
16. Hartmann TN, Burger JA, Glodek A, Fujii N, Burger M (2005) CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 24: 4462-4471. (Pubitemid 40961769)
17. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, et al. (1999) Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 5: 662-668. (Pubitemid 29289430)
18. Wedel SA, Raditchev IN, Jones J, Juengel E, Engl T, et al. (2008) CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancer. Mol Med Rep 1: 257-262.
19. Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, et al. (2003) Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89: 462-473. (Pubitemid 36648768)
20. Guo Y, Xu F, Lu T, Duan Z, Zhang Z (2012) Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 38: 904-910.
21. Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, et al. (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 58: 4640-4645. (Pubitemid 28480629)
22. Ueda T, Mawji NR, Bruchovsky N, Sadar MD (2002) Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J Biol Chem 277: 38087-38094. (Pubitemid 35157768)
23. Kasina S, Macoska JA (2012) The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor. Mol Cell Endocrinol 351: 249-263.
24. Lee SO, Lou W, Hou M, de Miguel F, Gerber L, et al. (2003) Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clin Cancer Res 9: 370-376. (Pubitemid 36109754)
25. Lee SO, Lou W, Johnson CS, Trump DL, Gao AC (2004) Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. Prostate 60: 178-186. (Pubitemid 38971829)
26. George DJ, Halabi S, Shepard TF, Sanford B, Vogelzang NJ, et al. (2005) The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480. Clin Cancer Res 11: 1815-1820. (Pubitemid 40471844)
27. Domingo-Domenech J, Oliva C, Rovira A, Codony-Servat J, Bosch M, et al. (2006) Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. Clin Cancer Res 12: 5578-5586. (Pubitemid 44497276)
28. Cunha GR, Hayward SW, Wang YZ, Ricke WA (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107: 1-10. (Pubitemid 37100079)
29. Lai KP, Yamashita S, Huang CK, Yeh S, Chang C (2012) Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. EMBO Mol Med 4: 791-807.
30. Ricke WA, Ishii K, Ricke EA, Simko J, Wang Y, et al. (2006) Steroid hormones stimulate human prostate cancer progression and metastasis. Int J Cancer 118: 2123-2131.
31. Yu Y, Liu L, Xie N, Xue H, Fazli L, et al. (2013) Expression and Function of the Progesterone Receptor in Human Prostate Stroma Provide Novel Insights to Cell Proliferation Control. J Clin Endocrinol Metab.
32. Dong X, Sweet J, Challis JR, Brown T, Lye SJ (2007) Transcriptional activity of androgen receptor is modulated by two RNA splicing factors, PSF and p54nrb. Mol Cell Biol 27: 4863-4875. (Pubitemid 47016137)
33. Liu LL, Xie N, Sun S, Plymate S, Mostaghel E, et al. (2013) Mechanisms of the androgen receptor splicing in prostate cancer cells. Oncogene.
34. Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, et al. (2001) Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Res 61: 423-427. (Pubitemid 32128590)
35. Olapade-Olaopa EO, MacKay EH, Taub NA, Sandhu DP, Terry TR, et al. (1999) Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma. Clin Cancer Res 5: 569-576. (Pubitemid 29131966)
36. Gabal SM, Habib FM, Helmy DO, Ibrahim MF (2007) Expression of estrogen receptor-B (ER-B) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features. J Egypt Natl Canc Inst 19: 239-248.
37. Li Y, Li CX, Ye H, Chen F, Melamed J, et al. (2008) Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion. J Cell Mol Med 12: 2790-2798.
38. McPherson SJ, Hussain S, Balanathan P, Hedwards SL, Niranjan B, et al. (2010) Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated. Proc Natl Acad Sci U S A 107: 3123-3128.
39. Tanner MJ, Welliver RC, Jr., Chen M, Shtutman M, Godoy A, et al. (2011) Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. PLoS One 6: e16027.
40. Dong X, Yu C, Shynlova O, Challis JR, Rennie PS, et al. (2009) p54nrb is a transcriptional corepressor of the progesterone receptor that modulates transcription of the labor-associated gene, connexin 43 (Gja1). Mol Endocrinol 23: 1147-1160.
41. Xie N, Liu L, Li Y, Yu C, Lam S, et al. (2012) Expression and function of myometrial PSF suggest a role in progesterone withdrawal and the initiation of labor. Mol Endocrinol 26: 1370-1379.
42. Jacobsen BM, Richer JK, Schittone SA, Horwitz KB (2002) New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. J Biol Chem 277: 27793-27800. (Pubitemid 34966724)
43. Hardy DB, Janowski BA, Chen CC, Mendelson CR (2008) Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms. Mol Endocrinol 22: 1812-1824.
44. Lim CS, Baumann CT, Htun H, Xian W, Irie M, et al. (1999) Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras. Mol Endocrinol 13: 366-375. (Pubitemid 29113869)
45. Arnett-Mansfield RL, DeFazio A, Mote PA, Clarke CL (2004) Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium. J Clin Endocrinol Metab 89: 1429-1442. (Pubitemid 38368448)
46. Daniel AR, Lange CA (2009) Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proc Natl Acad Sci U S A 106: 14287-14292.
47. Gao L, Schwartzman J, Gibbs A, Lisac R, Kleinschmidt R, et al. (2013) Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation. PLoS One 8: e63563.
48. Sung ML, Wu CC, Chang HI, Yen CK, Chen HJ, et al. (2009) Shear stress inhibits homocysteine-induced stromal cell-derived factor-1 expression in endothelial cells. Circ Res 105: 755-763.
49. Kurita T, Young P, Brody JR, Lydon JP, O'Malley BW, et al. (1998) Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis. Endocrinology 139: 4708-4713. (Pubitemid 28487790)